Let’s Not Forget About the Other Respiratory Viruses
With all the focus on COVID-19, let’s not forget about rhinoviruses, influenza, RSV, and adenoviruses. With coronaviruses taking over our ...
With all the focus on COVID-19, let’s not forget about rhinoviruses, influenza, RSV, and adenoviruses. With coronaviruses taking over our ...
The Naval Medical Research Unit 6 (NAMRU-6) is seeking to purchase laboratory reagents to be used for molecular diagnosis of ...
Broad-spectrum antiviral Brincidofovir has shown favorable tolerability in its intravenous formulation, according to preclinical data presented by Chimerix at the ...
Soligenix, Inc. this week announced positive preliminary proof-of-concept results from its collaboration with University of Hawaiʻi at Mānoa (UH Mānoa) ...
Oral adenovirus vaccine tablets. Image credit: U.S. Army Medical Materiel Development Activity The Adenovirus vaccine has been protecting military trainees ...
The National Institute of Allergy and Infectious Diseases (NIAID) Division of Microbiology and Infectious Diseases (DMID) has a requirement to ...
Data from a Phase 1 study of a preventive Ebola vaccine regimen suggests that the regimen was well-tolerated by healthy ...
Protein Sciences Corporation this week announced that they have been awarded a Phase I Small Business Innovation Research (SBIR) grant ...
The Naval Medical Logistics Command (NMLC) recently announced intentions to award a sole source contract to BioFire Defense in support of ...
The U.S. Department of Health and Human Services (HHS) has announced intentions to procure up to 1.7 million courses of ...
Soligenix, Inc. last week announced a collaboration agreement with Axel Lehrer, PhD, of the UH Mānoa Department of Tropical Medicine, ...
The Naval Health Research Center (NHRC) has issued an updated Broad Agency Announcement (BAA) identifying scientific and technical areas of ...
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T), Chemical and Biological Division (CBD), Agricultural Defense Branch ...
The candidate Ebola vaccine developed collaboratively by scientists at NIAID’s Vaccine Research Center and GlaxoSmithKline (GSK) was shown to be ...
The U.S. federal government has recently awarded the following notable contract related to the field of chemical, biological, radiological and ...
Health and Human Services today announced a declaration under the Public Readiness and Emergency Preparedness (PREP) Act to facilitate the ...
The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for the development of therapeutic strategies for select ...
A 39-year-old woman, the first participant enrolled in VRC 207, receives a dose of the investigational NIAID/GSK Ebola vaccine. Results ...
Swissmedic, the Swiss regulatory authority for therapeutic products, has approved a second Swiss trial of an experimental Ebola vaccine. The ...
A breathable vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus. A ...